IRIDEX Gross Margin 2012-2026 | IRIX
Current and historical gross margin for IRIDEX (IRIX) over the last 10 years. The current gross profit margin for IRIDEX as of March 31, 2026 is %.
| IRIDEX Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.05B | $0.02B | 35.85% |
| 2025-12-31 | $0.05B | $0.02B | 35.85% |
| 2025-09-30 | $0.05B | $0.02B | 39.22% |
| 2025-06-30 | $0.05B | $0.02B | 39.22% |
| 2025-03-31 | $0.05B | $0.02B | 40.00% |
| 2024-12-31 | $0.05B | $0.02B | 38.00% |
| 2024-09-30 | $0.05B | $0.02B | 36.73% |
| 2024-06-30 | $0.05B | $0.02B | 40.00% |
| 2024-03-31 | $0.05B | $0.02B | 40.00% |
| 2023-12-31 | $0.05B | $0.02B | 42.31% |
| 2023-09-30 | $0.06B | $0.02B | 43.64% |
| 2023-06-30 | $0.06B | $0.02B | 42.11% |
| 2023-03-31 | $0.06B | $0.03B | 43.10% |
| 2022-12-31 | $0.06B | $0.03B | 43.86% |
| 2022-09-30 | $0.06B | $0.02B | 42.11% |
| 2022-06-30 | $0.06B | $0.02B | 43.64% |
| 2022-03-31 | $0.05B | $0.02B | 44.44% |
| 2021-12-31 | $0.05B | $0.02B | 43.40% |
| 2021-09-30 | $0.05B | $0.02B | 46.00% |
| 2021-06-30 | $0.05B | $0.02B | 45.65% |
| 2021-03-31 | $0.04B | $0.02B | 43.59% |
| 2020-12-31 | $0.04B | $0.02B | 44.44% |
| 2020-09-30 | $0.04B | $0.02B | 41.67% |
| 2020-06-30 | $0.04B | $0.02B | 39.47% |
| 2020-03-31 | $0.04B | $0.02B | 42.86% |
| 2019-12-31 | $0.04B | $0.02B | 40.91% |
| 2019-09-30 | $0.04B | $0.02B | 41.86% |
| 2019-06-30 | $0.04B | $0.02B | 44.19% |
| 2019-03-31 | $0.04B | $0.02B | 41.86% |
| 2018-12-31 | $0.04B | $0.02B | 42.86% |
| 2018-09-30 | $0.04B | $0.02B | 36.59% |
| 2018-06-30 | $0.04B | $0.01B | 34.15% |
| 2018-03-31 | $0.04B | $0.01B | 34.15% |
| 2017-12-31 | $0.04B | $0.01B | 34.15% |
| 2017-09-30 | $0.04B | $0.02B | 40.91% |
| 2017-06-30 | $0.04B | $0.02B | 41.86% |
| 2017-03-31 | $0.05B | $0.02B | 44.44% |
| 2016-12-31 | $0.05B | $0.02B | 44.68% |
| 2016-09-30 | $0.05B | $0.02B | 43.48% |
| 2016-06-30 | $0.05B | $0.02B | 45.65% |
| 2016-03-31 | $0.04B | $0.02B | 44.19% |
| 2015-12-31 | $0.04B | $0.02B | 45.24% |
| 2015-09-30 | $0.04B | $0.02B | 47.62% |
| 2015-06-30 | $0.04B | $0.02B | 47.62% |
| 2015-03-31 | $0.04B | $0.02B | 47.73% |
| 2014-12-31 | $0.04B | $0.02B | 48.84% |
| 2014-09-30 | $0.04B | $0.02B | 47.62% |
| 2014-06-30 | $0.04B | $0.02B | 47.62% |
| 2014-03-31 | $0.04B | $0.02B | 47.50% |
| 2013-12-31 | $0.04B | $0.02B | 46.15% |
| 2013-09-30 | $0.04B | $0.02B | 45.95% |
| 2013-06-30 | $0.04B | $0.02B | 45.71% |
| 2013-03-31 | $0.03B | $0.02B | 47.06% |
| 2012-12-31 | $0.03B | $0.02B | 48.48% |
| 2012-09-30 | $0.03B | $0.02B | 48.48% |
| 2012-06-30 | $0.03B | $0.02B | 48.48% |
| 2012-03-31 | $0.03B | $0.02B | 48.48% |
| 2011-12-31 | $0.03B | $0.02B | 48.48% |
| 2011-09-30 | $0.03B | $0.01B | 52.00% |
| 2011-06-30 | $0.03B | $0.01B | 50.00% |
| 2011-03-31 | $0.03B | $0.02B | 50.00% |
| 2010-12-31 | $0.03B | $0.02B | 48.48% |
| 2010-09-30 | $0.03B | $0.02B | 48.39% |
| 2010-06-30 | $0.03B | $0.02B | 50.00% |
| 2010-03-31 | $0.03B | $0.02B | 48.39% |
| 2009-12-31 | $0.03B | $0.02B | 48.39% |
| 2009-09-30 | $0.04B | $0.02B | 45.45% |
| 2009-06-30 | $0.05B | $0.02B | 43.48% |
| 2009-03-31 | $0.05B | $0.02B | 41.67% |
| 2008-12-31 | $0.05B | $0.02B | 41.67% |
| 2008-09-30 | $0.05B | $0.02B | 42.00% |
| 2008-06-30 | $0.05B | $0.02B | 42.31% |
| 2008-03-31 | $0.05B | $0.02B | 44.44% |
| 2007-12-31 | $0.06B | $0.02B | 42.86% |
| 2007-09-30 | $0.05B | $0.02B | 45.10% |
| 2007-06-30 | $0.05B | $0.02B | 47.83% |
| 2007-03-31 | $0.04B | $0.02B | 50.00% |
| 2006-12-31 | $0.04B | $0.02B | 52.78% |
| 2006-09-30 | $0.04B | $0.02B | 51.35% |
| 2006-06-30 | $0.04B | $0.02B | 51.35% |
| 2006-03-31 | $0.04B | $0.02B | 51.35% |
| 2005-12-31 | $0.04B | $0.02B | 52.78% |
| 2005-09-30 | $0.04B | $0.02B | 51.43% |
| 2005-06-30 | $0.03B | $0.02B | 47.06% |
| 2005-03-31 | $0.03B | $0.02B | 45.45% |
| 2004-12-31 | $0.03B | $0.01B | 43.75% |
| 2004-09-30 | $0.03B | $0.01B | 43.75% |
| 2004-06-30 | $0.03B | $0.02B | 46.88% |
| 2004-03-31 | $0.03B | $0.01B | 45.16% |
| 2003-12-31 | $0.03B | $0.01B | 45.16% |
| 2003-09-30 | $0.03B | $0.01B | 43.75% |
| 2003-06-30 | $0.03B | $0.01B | 41.94% |
| 2003-03-31 | $0.03B | $0.01B | 41.94% |
| 2002-12-31 | $0.03B | $0.01B | 41.94% |
| 2002-09-30 | $0.03B | $0.01B | 44.83% |
| 2002-06-30 | $0.03B | $0.01B | 44.83% |
| 2002-03-31 | $0.03B | $0.01B | 48.28% |
| 2001-12-31 | $0.03B | $0.01B | 46.43% |
| 2001-09-30 | $0.03B | $0.01B | 46.43% |
| 2001-06-30 | $0.03B | $0.01B | 48.28% |
| 2001-03-31 | $0.03B | $0.02B | 48.39% |
| 2000-12-31 | $0.03B | $0.02B | 54.55% |
| 2000-09-30 | $0.03B | $0.02B | 57.58% |
| 2000-06-30 | $0.03B | $0.02B | 61.29% |
| 2000-03-31 | $0.03B | $0.02B | 64.29% |
| 1999-12-31 | $0.03B | $0.02B | 61.54% |
| 1999-09-30 | $0.03B | $0.02B | 60.00% |
| 1999-06-30 | $0.02B | $0.01B | 58.33% |
| 1999-03-31 | $0.02B | $0.01B | 58.33% |
| 1998-12-31 | $0.02B | $0.01B | 58.33% |
| 1998-09-30 | $0.02B | $0.02B | 69.57% |
| 1998-06-30 | $0.02B | $0.02B | 69.57% |
| 1998-03-31 | $0.02B | $0.02B | 71.43% |
| 1997-12-31 | $0.02B | $0.01B | 77.78% |
| 1997-09-30 | $0.02B | $0.01B | 70.59% |
| 1997-06-30 | $0.02B | $0.01B | 73.33% |
| 1997-03-31 | $0.01B | $0.01B | 76.92% |
| 1996-12-31 | $0.01B | $0.01B | 75.00% |
| 1996-06-30 | $0.01B | $0.01B | 83.33% |
| 1996-03-31 | $0.01B | $0.01B | 83.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Laser Systems and Components | $0.017B | $0.053B |
| IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IPG Photonics (IPGP) | United States | $5.404B | 89.66 |
| Applied Energetics (AERG) | United States | $0.246B | 0.00 |